154 related articles for article (PubMed ID: 26487757)
21. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
Rathe M; Carlsen NL; Oxhøj H
Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
[TBL] [Abstract][Full Text] [Related]
22. Thyroid Radiation Dose and Other Risk Factors of Thyroid Carcinoma Following Childhood Cancer.
de Vathaire F; Haddy N; Allodji RS; Hawkins M; Guibout C; El-Fayech C; Teinturier C; Oberlin O; Pacquement H; Diop F; Kalhouche A; Benadjaoud M; Winter D; Jackson A; Bezin Mai-Quynh G; Benabdennebi A; Llanas D; Veres C; Munzer M; Nguyen TD; Bondiau PY; Berchery D; Laprie A; Deutsch E; Lefkopoulos D; Schlumberger M; Diallo I; Rubino C
J Clin Endocrinol Metab; 2015 Nov; 100(11):4282-90. PubMed ID: 26327481
[TBL] [Abstract][Full Text] [Related]
23. Cardiotoxicity and cardioprotection in childhood cancer.
Lipshultz SE; Sambatakos P; Maguire M; Karnik R; Ross SW; Franco VI; Miller TL
Acta Haematol; 2014; 132(3-4):391-9. PubMed ID: 25228565
[TBL] [Abstract][Full Text] [Related]
24. Anthracycline cardiotoxicity in long-term survivors of childhood cancer.
Scully RE; Lipshultz SE
Cardiovasc Toxicol; 2007; 7(2):122-8. PubMed ID: 17652816
[TBL] [Abstract][Full Text] [Related]
25. Cardiotoxicity after childhood cancer: beginning with the end in mind.
Lipshultz SE; Adams MJ
J Clin Oncol; 2010 Mar; 28(8):1276-81. PubMed ID: 20142585
[No Abstract] [Full Text] [Related]
26. Age at menopause and its influencing factors in a cohort of survivors of childhood cancer: earlier but rarely premature.
Thomas-Teinturier C; El Fayech C; Oberlin O; Pacquement H; Haddy N; Labbé M; Veres C; Guibout C; Diallo I; De Vathaire F
Hum Reprod; 2013 Feb; 28(2):488-95. PubMed ID: 23154067
[TBL] [Abstract][Full Text] [Related]
27. Echocardiographic surveillance for asymptomatic late-onset anthracycline cardiomyopathy in childhood cancer survivors.
Abosoudah I; Greenberg ML; Ness KK; Benson L; Nathan PC
Pediatr Blood Cancer; 2011 Sep; 57(3):467-72. PubMed ID: 21280201
[TBL] [Abstract][Full Text] [Related]
28. Subclinical late cardiac toxicity in childhood cancer survivors: impact on self-reported health.
Cox CL; Rai SN; Rosenthal D; Phipps S; Hudson MM
Cancer; 2008 Apr; 112(8):1835-44. PubMed ID: 18311782
[TBL] [Abstract][Full Text] [Related]
29. Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer.
Guldner L; Haddy N; Pein F; Diallo I; Shamsaldin A; Dahan M; Lebidois J; Merlet P; Villain E; Sidi D; Sakiroglu O; Hartmann O; Leftakopoulos D; de Vathaire F
Radiother Oncol; 2006 Oct; 81(1):47-56. PubMed ID: 16989913
[TBL] [Abstract][Full Text] [Related]
30. Anthracycline cardiotoxicity in childhood.
Ruggiero A; Ridola V; Puma N; Molinari F; Coccia P; De Rosa G; Riccardi R
Pediatr Hematol Oncol; 2008 Jun; 25(4):261-81. PubMed ID: 18484471
[TBL] [Abstract][Full Text] [Related]
31. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
Jensen BV
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
[TBL] [Abstract][Full Text] [Related]
32. Cardiotoxicity of oncological treatment in children.
Kucharska W; Negrusz-Kawecka M; Gromkowska M
Adv Clin Exp Med; 2012; 21(3):281-8. PubMed ID: 23214190
[TBL] [Abstract][Full Text] [Related]
33. NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors.
Zidan A; Sherief LM; El-sheikh A; Saleh SH; Shahbah DA; Kamal NM; Sherbiny HS; Ahmad H
Dis Markers; 2015; 2015():513219. PubMed ID: 25960594
[TBL] [Abstract][Full Text] [Related]
34. Echocardiographic Detection of Cardiac Dysfunction in Childhood Cancer Survivors: How Long Is Screening Required?
Ramjaun A; AlDuhaiby E; Ahmed S; Wang L; Yu E; Nathan PC; Hodgson DC
Pediatr Blood Cancer; 2015 Dec; 62(12):2197-203. PubMed ID: 26146944
[TBL] [Abstract][Full Text] [Related]
35. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study.
van Dalen EC; van der Pal HJ; Kok WE; Caron HN; Kremer LC
Eur J Cancer; 2006 Dec; 42(18):3191-8. PubMed ID: 16987655
[TBL] [Abstract][Full Text] [Related]
36. Growth-differentiation Factor-15 and Tissue Doppler Imaging in Detection of Anthracycline-induced Cardiomyopathy During Therapy of Childhood Cancers.
Kaya F; Arslan D; Vatansev H; Kose D; Cimen D; Akyurek F; Oran B; Koksal Y
J Pediatr Hematol Oncol; 2016 Apr; 38(3):e107-12. PubMed ID: 26907646
[TBL] [Abstract][Full Text] [Related]
37. Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study.
Brown TR; Vijarnsorn C; Potts J; Milner R; Sandor GG; Fryer C
Pediatr Blood Cancer; 2013 May; 60(5):842-8. PubMed ID: 23382019
[TBL] [Abstract][Full Text] [Related]
38. Subclinical cardiac dysfunction and exercise performance in childhood cancer survivors.
De Caro E; Smeraldi A; Trocchio G; Calevo M; Hanau G; Pongiglione G
Pediatr Blood Cancer; 2011 Jan; 56(1):122-6. PubMed ID: 21058389
[TBL] [Abstract][Full Text] [Related]
39. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.
Kremer LC; van Dalen EC; Offringa M; Ottenkamp J; Voûte PA
J Clin Oncol; 2001 Jan; 19(1):191-6. PubMed ID: 11134212
[TBL] [Abstract][Full Text] [Related]
40. No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer.
van Santen HM; Vulsma T; Dijkgraaf MG; Blumer RM; Heinen R; Jaspers MW; Geenen MM; Offringa MO; de Vijlder JJ; van den Bos C
J Clin Endocrinol Metab; 2003 Aug; 88(8):3657-63. PubMed ID: 12915651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
